|
Volumn 15, Issue 1, 2005, Pages 41-52
|
Why drug prices are high in sub-Saharan Africa. Analysis of price structure: The case of Senegal;Pourquoi le prix des médicaments est élevé dans les pays d'Afrique subsaharienne. Analyse de la structure des prix: L'Exemple du Sénégal
|
Author keywords
Access to drug; Cost; Drug; Health policy; Senegal
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALUMINUM;
AMODIAQUINE;
AMOXICILLIN;
AMPICILLIN;
ANTACID AGENT;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIPYRETIC ANALGESIC AGENT;
BENZATHINE;
BENZATHINE PENICILLIN;
CHLOROQUINE;
CIMETIDINE;
CIPROFLOXACIN;
COTRIMOXAZOLE;
DIAZEPAM;
DOXYCYCLINE;
FANSIDAR;
GENERIC DRUG;
GENTAMICIN;
MAGNESIUM;
METRONIDAZOLE;
NICLOSAMIDE;
NYSTATIN;
OXACILLIN;
PARACETAMOL;
PRAZIQUANTEL;
PYRIDOXINE;
PYRIMETHAMINE;
QUININE;
SULFADOXINE;
TETRACYCLINE;
THIAMINE;
TIABENDAZOLE;
ADULT;
AFRICA;
ARTICLE;
CHILD;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
FEMALE;
FRANCE;
HEALTH CARE ACCESS;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PHARMACY;
PRESCRIPTION;
REIMBURSEMENT;
SENEGAL;
AFRICA SOUTH OF THE SAHARA;
COSTS AND COST ANALYSIS;
PHARMACEUTICAL PREPARATIONS;
SENEGAL;
|
EID: 20344395645
PISSN: 11575999
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (9)
|